Orchard Financial Statements From 2010 to 2024
| ORTXDelisted Stock | USD 16.70 0.00 0.00% |
Check Orchard Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orchard main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Orchard financial statements analysis is a perfect complement when working with Orchard Therapeutics Valuation or Volatility modules.
Orchard |
Orchard Therapeutics PLC Company Return On Equity Analysis
Orchard Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Orchard Therapeutics Return On Equity | -0.72 |
Most of Orchard Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Orchard Therapeutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Orchard Therapeutics PLC has a Return On Equity of -0.7151. This is 97.02% lower than that of the Biotechnology sector and 98.04% lower than that of the Health Care industry. The return on equity for all United States stocks is 130.68% higher than that of the company.
Orchard Therapeutics PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orchard Therapeutics's current stock value. Our valuation model uses many indicators to compare Orchard Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orchard Therapeutics competition to find correlations between indicators driving Orchard Therapeutics's intrinsic value. More Info.Orchard Therapeutics PLC is rated below average in return on equity category among related companies. It is regarded fifth in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Orchard Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Orchard Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orchard Therapeutics' earnings, one of the primary drivers of an investment's value.About Orchard Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Orchard Therapeutics income statement, its balance sheet, and the statement of cash flows. Orchard Therapeutics investors use historical funamental indicators, such as Orchard Therapeutics's revenue or net income, to determine how well the company is positioned to perform in the future. Although Orchard Therapeutics investors may use each financial statement separately, they are all related. The changes in Orchard Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Orchard Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Orchard Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Orchard Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom. Orchard Therapeutics is traded on NASDAQ Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Orchard Stock
If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |